Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase in the United States

By sjmartinez • February 21, 2025

Pak K, Sachar R, Saab S. Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase in the United States. Dig Dis Sci. 2025 Feb 20. doi: 10.1007/s10620-025-08909-z. Epub ahead of print. PMID: 39979574.

Tags: Digestive Diseases, Gray zone, HCC, hepatitis B, Immune-tolerant, Publications

High concentrations of L-lysine cause mitochondrial damage and necrosis in isolated pancreatic acinar cells

Végh ET, Balla Z, Dágó Á, Salamah O, Tóth B, Elperin J, Speakman S, Shalbueva N, Pallagi P, Rázga Z, Kiss L, Gukovskaya A, Rakonczay[...]

Social bonds and health: exploring the impact of social relations on oxytocin and brain-gut communication in shaping obesity

Zhang X, Dong TS, Gee GC, Kilpatrick LA, Beltran-Sanchez H, Wang MC, Vaughan A, Church A. Social bonds and health: exploring the impact of social[...]

Unraveling the Complexity: A Case of Systemic Lupus Erythematosus, Warm Autoimmune Hemolytic Anemia, and Autoimmune Cholangitis

Sharma R, Dao KT, Garcia-Corella J, Dhillon H, Kalha I, Kim S, Stull WR, Petersen G. Unraveling the Complexity: A Case of Systemic Lupus Erythematosus,[...]